esophageal cancer and it has been proved as a potent radiation sensitizer. There have been multiple studies evaluating paclitaxel-based chemoradiation in esophageal cancer, the results of which are inspiring. However, which regimen, among paclitaxel in combination with cisplatin (TP), carboplatin (TC) and fluorouracil (TF) concurrent with radiotherapy, provides best prognosis with minimum adverse events is still considered far from resolved and very few studies focus on this field. The purpose of this study is to confirm the priority of TF to TP or TC concurrent with radiotherapy in terms of overall survival and propose a feasible and effective plan for patients with local advanced esophageal cancer.
How many people will take part in the study?
About 321 people will take part in this study.
What will happen if I take part in this research study?
You will be randomized and allocated in a 1:1:1 ratio to the three treatment groups (TF, TP or TC). You will receive radiotherapy combined with concurrent chemotherapy.
Radiotherapy will begin on day 1, concurrent with the beginning of cycle 1 of chemotherapy.
Radiation therapy
Same radiation therapy will be delivered in all three treatment groups. Radiotherapy will be delivered with photons (≥6 MV) to a total dose of 61.2Gy in 34 fractions. You will be treated 5 days per week at 1.8Gy/d. During each treatment, blood tests will be performed to monitor blood counts, kidney function, liver function and electrolyte levels. Ultrasound, barium swallow and CT scan with contrast will be performed to evaluate the status of disease.
Chemotherapy

How long will I be in the study?
After your treatment is completed, you will be seen in follow-up visits with your doctor every 3 months in years 1-2, every 6 months in years 3-5 and then once a year for your lifetime.
Can I stop being in the study?
Yes. You can decide to stop at any time. Tell the study doctor if you are thinking about stopping or decide to stop. He or she will tell you how to stop safely.
It is important to tell the study doctor if you are thinking about stopping so he or she can evaluate any risks from the treatment. Another reason to tell your study doctor that you are thinking about stopping is to discuss what follow-up care and testing could be most helpful for you.
The study doctor may stop you from taking part in this study at any time if he/she believes it is in your best interest, if you do not follow the study rules, or if the study is stopped.
What side effects or risks can I expect from being in the study?
You may have side effects while on the study. Everyone taking part in the study will be watched carefully for any side effects. However, doctors don't know all the side effects that may happen. Side effects may be mild or very serious. There also is a risk of death. Taking part in this study may or may not make your health better. While researchers hope these treatment regimens will be more useful against cancer compared to the usual treatment, there is no proof of this yet. We do know that the information from this study will help researchers learn more about these combinations of drugs as a treatment for cancer. This information could help future cancer patients.
Will my medical information be kept private?
We will do our best to make sure that the personal information in your medical record will be kept private. Your personal information may be given out if required by law. If information from this study is published or presented at scientific meetings, your name and other personal information will not be used.
What happens if I am injured because I took part in this study?
It is important that you tell your study doctor if you feel that you have been injured because of taking part in this study. You will get medical treatment if you are injured as a result of taking part in this study. You and/or your health plan will be charged for this treatment. The study will not pay for medical treatment.
What are my rights if I take part in this study?
Taking part in this study is your choice. You may choose either to take part or not to take part in the study. If you decide to take part in this study, you may leave the study at any time. No matter what decision you make, there will be no penalty to you and you will not lose any of your regular benefits. Leaving the study will not affect your medical care. You can still get your medical care from our center.
We will tell you about new information or changes in the study that may affect your health or your willingness to continue in the study.
In the case of injury resulting from this study, you do not lose any of your legal rights to seek payment by signing this form.
WHO CAN ANSWER MY QUESTIONS ABOUT THE STUDY?
You can talk to your study doctor about any questions or concerns you have about this study. Contact your study doctor, Kuaile Zhao, at 021-64175590. 
